Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.
Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.
复制标题
DOI:
10.1016/j.jacc.2021.11.061
复制
发表时间:
2022-03-08
影响因子:
24
通讯作者:
Sandhu, Alexander T.
中科院分区:
文献类型:
--
作者:
Zheng, Jimmy;Heidenreich, Paul A.;Kohsaka, Shun;Fearon, William F.;Sandhu, Alexander T.
Coronary artery disease (CAD) is the most common cause of new-onset heart failure (HF). Although guidelines recommend ischemic evaluation in this population, testing has historically been underutilized. This study aimed to identify contemporary trends in CAD testing for new-onset HF patients, particularly after publication of the Surgical Treatment for Ischemic Heart Failure Extension Study (STICHES), and to characterize geographic and clinician-level variability in testing patterns. We determined the proportion of incident HF patients who received CAD testing from 2004–2019 using an administrative claims database covering commercial insurance and Medicare. We identified demographic and clinical predictors of CAD testing during the 90 days before and after initial diagnosis. Patients were grouped by their county of residence to assess national variation. Patients were then linked to their primary care physician and/or cardiologist to evaluate variation across clinicians. Among 558,322 new-onset HF patients, 34.8% underwent CAD testing and 9.3% underwent revascularization. After multivariable adjustment, patients who underwent CAD testing were more likely to be younger, male, diagnosed in an acute care setting, and have systolic dysfunction or recent cardiogenic shock. Incidence of CAD testing remained flat without significant change post-STICHES. Covariate-adjusted testing rates varied from 20–45% across counties. The likelihood of testing was higher among patients co-managed by a cardiologist (adjusted OR 5.12, 95% CI 4.98–5.27) but varied substantially across cardiologists (IQR: 50.9–62.4%). Most new-onset HF patients across inpatient and outpatient settings did not receive timely testing for CAD. Substantial variability in testing persists across regions and clinicians. Coronary artery disease (CAD) testing in patients with new-onset heart failure (HF) has historically been underutilized. The present study leverages a large administrative claims database to determine contemporary trends in CAD testing between inpatient and outpatient settings, across geographies, and among clinicians. Our results suggest that rates of CAD testing in new-onset HF patients remain low, even after publication of the Surgical Treatment for Ischemic Heart Failure Extension Study in 2016. Most new-onset HF patients across inpatient and outpatient settings did not receive timely testing for CAD. Substantial variability in testing rates persists across clinicians and geographic regions.
登录
查看更多内容
DOI:
10.1161/circheartfailure.110.938175
发表时间:
2010-11
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Goyal A;Norton CR;Thomas TN;Davis RL;Butler J;Ashok V;Zhao L;Vaccarino V;Wilson PW
通讯作者:
Wilson PW
影响因子:
18.2
作者:
Ezekowitz, Justin A.;Kaul, Padma;McAlister, Finlay A.
通讯作者:
McAlister, Finlay A.
影响因子:
4.8
作者:
Flaherty, James D.;Rossi, Joseph S.;Gheorghiade, Mihai
通讯作者:
Gheorghiade, Mihai
影响因子:
24
作者:
Doshi, Darshan;Ben-Yehuda, Ori;Kirtane, Ajay J.
通讯作者:
Kirtane, Ajay J.
影响因子:
6.3
作者:
Clarke, Philippa;Wheaton, Blair
通讯作者:
Wheaton, Blair